Research shows that women and people of color often suffer from advanced heart and vascular disease at disproportionately high rates. But their burden doesn’t end there.

“It's an experience that I hope no one goes through, but it's an empowering experience.” 

According to Worcester Polytechnic Institute (WPI), the future of medicine is the ability to remotely monitor patients in a simple and accurate way. The new sensor that they’ve developed does just that.

Alibaba Group’s research institute DAMO Academy has developed an AI-powered tool that can screen for early signs of pancreatic cancer, one of the most fatal cancers worldwide.

INSPIRE is the perfect word to describe Safeway Store Director Rob Jones. He was recently spotlighted in Providence General Foundation’s INSPIRE magazine for his phenomenal fundraising work through Pink the Rink for breast cancer patients.

On this episode of Healthy Outcomes, our host Mark Ross interviews Baker Tilly’s Chief Diversity Officer, Shane Lloyd.

Quest Diagnostics recently provided no-cost Blueprint for Wellness® testing to more than 100 local community members who attended a wellness day in the Mississippi Delta region.

In light of economic downturns and austerity measures, it is important to focus on the broader value created for society through a total cost calculation, including societal costs.

Nucleus Genomics is realizing the dream set into motion long ago by the Human Genome Project: to use the power of genomics to help people live lives that are as healthy and long as possible.

Relationship leverages Quest's sequencing and specimen collection expertise with Scipher's precision medicine technology

We're proud to have contributed to this milestone announced by the World Health Organization - marking the elimination of visceral leishmaniasis (VL) as a public health problem in Bangladesh.

Two key initiatives were launched in 2022 to reduce unplanned events, in particular, Process Safety Containment Events (PSCEs). Both provided global guidance with the flexibility to tailor at the site and plant level.

Managing the holidays can be challenging for individuals with substance use disorders (SUDs), as this time of year often involves social gatherings and increased stress.

The International WELL Building Institute (IWBI) today announces a new collaboration with the Green Building Council Italia (GBC Italia), a part of the World Green Building Council (WorldGBC), representing the world's largest organization for…

When Olebogeng Moumakwe strides through the maze of streets that weave through Diepsloot, people often call out to her in recognition – whether she remembers them or not.

Global health has climbed higher on the political agenda in recent years, partly due to the Covid-19 pandemic. There are a number of key global health moments in the coming years where the global community are addressing Universal Health Coverage,…

Shatterproof along with a coalition of law enforcement and national nonprofit and community-based organizations devoted to fighting against the fentanyl crisis plaguing our nation sent a letter to the leaders of the House and Senate urging them to…

Now, over a decade later, Eleanor shares how Ivan’s diagnosis changed both of their lives—and how a Boston Scientific treatment helped them take a turn for the better.

On this episode of Healthy Outcomes, our host Mark Ross interviews Baker Tilly’s Heather Herc, director, and Brad Gummig, senior manager.

We have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - disease areas with vulnerable patient populations who are often treated…

When the clinic first opened – built with funds provided by Viatris in partnership with Rhiza Babuyile, a local nonprofit – Sister Thandi cried.

More than 1,100 Community Health Centers – also called Federally Qualified Health Centers, or FQHC – today provide affordable, comprehensive care to over 30 million children and adults across the United States.

Cadence Molecular Sciences (OpenEye)—a business unit of Cadence Design Systems (Nasdaq: CDNS)—will provide OpenEye’s molecular design software to power the open-science AI-driven Structure-enabled Antiviral Platform (ASAP) Discovery Consortium.

With localized impacts from a global program, IP has made a significant difference in the fight to end Period Poverty.

Signal-C® uses next generation sequencing (NGS) and bioinformatics to identify methylated DNA patterns and fragments shed by colorectal cancer tumors circulating in the blood stream.